Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
GSK plc

GSK plc (GSK) Stock Overview

Explore GSK plc’s financial performance, market position, analyst ratings, and future outlook.

GSK●NYSE
HealthcareDrug Manufacturers - General
$52.16
$0.80(1.51%)
U.S. Market opens in 1h 34m

GSK plc (GSK)

Meyka AI Score

Z

Key Financials

Market Cap104.6B
P/E Ratio16.01
EPS (TTM)$4.63
ROE0.24%
Fundamental Analysis

AI Price Forecasts

1 Month$55.17
3 Months$55.95
1 Year Target$58.26

GSK Stock Analysis & Investment Overview (NYSE)

Our AI-powered analysis of GSK plc (NYSE: GSK) gives investors deep insight into how the stock performs on the NYSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, GSK plc's NYSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of GSK on the NYSE shows an RSI of 50.28, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $58.26 for the NYSE listing.

Key metrics behind GSK plc's NYSE-traded stock include a P/E ratio of 16.01 and a market capitalization of 104.6B. Combined with our AI analysis, these give both institutional and retail investors a clear view of GSK on the NYSE.

Price Performance (NYSE: GSK)

1-Day Change
-1.45%
5-Day Change
0.25%
1-Month Change
-1.12%
3-Month Change
3.53%
6-Month Change
-11.27%
Year-to-Date (YTD) Change
6.42%
1-Year Change
38.40%
3-Year Change
48.77%
5-Year Change
28.39%
All-Time (Max) Change
7852.76%

Contact Information

https://www.gsk.com
44 20 8047 5000
79 New Oxford Street, London, GL, WC1A 1DG

Company Facts

668,410 Employees
IPO DateMar 28, 1980
CountryGB
Actively Trading

Frequently Asked Questions